By [ad_1]
Zydus Lifesciences Ltd.’s second-quarter after-tax profit dropped but was in line with estimates.
Net profit stood at Rs 523 crore in the three months ended September 30, down 83% over a year earlier, according to an exchange filing by the Ahmedabad-based drugmaker. That compares with the Rs 545 crore consensus estimate of analysts tracked by Bloomberg.
[ad_2]
Source link
What is your reaction?
Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0
